Pharmacokinetics and disposition of anlotinib, an oral tyrosine kinase inhibitor, in experimental animal species.
Zhong CC, Chen F, Yang JL, Jia WW, Li L, Cheng C, Du FF, Zhang SP, Xie CY, Zhang NT, Olaleye OE, Wang FQ, Xu F, Lou LG, Chen DY, Niu W, Li C.
Zhong CC, et al. Among authors: li c, li l.
Acta Pharmacol Sin. 2018 Jun;39(6):1048-1063. doi: 10.1038/aps.2017.199. Epub 2018 Apr 5.
Acta Pharmacol Sin. 2018.
PMID: 29620050
Free PMC article.